XAIR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Beyond Air Inc (XAIR) is not a good buy for a beginner investor with a long-term strategy at this time. The stock is in a bearish technical trend, lacks positive trading signals, and faces significant financial challenges despite revenue growth. Additionally, there are no strong catalysts or recent influential trades to support a bullish case.
The stock is in a bearish trend with SMA_200 > SMA_20 > SMA_5. MACD is negative and contracting, RSI is neutral at 42.201, and the pre-market price is down 4.75%. Key support lies at 0.455, and resistance is at 0.605. Short-term price projections indicate a 90% chance of a -3.05% decline in the next day.
Revenue increased by 104.66% YoY in Q3 2026, indicating potential growth in the company's operations.
No recent news, insider trading, or congress trading activity to provide support.
In Q3 2026, revenue increased to $2,194,000 (up 104.66% YoY), but net income dropped to -$7,336,000 (down 43.71% YoY). EPS fell to -0.85 (down 71.28% YoY), and gross margin declined to 13.67% (down 168.15% YoY).
JonesResearch reduced the price target to $2 from $6 but maintained a Buy rating, citing the potential commercialization of the LungFit PH system as a key driver for future growth. However, FDA approval is not expected until late 2026, delaying any significant revenue impact.
